GMP BridgeBRIEFING
MONTHLY  ·  ACCESS ON REQUEST

GMP Bridge Briefing

From signal to decision. A monthly brief for Quality, Operations and CMC leaders responsible for consequential GMP decisions.

Written by Felipe Fontanet, Founder of GMP Bridge. We review every request to keep the Briefing relevant to active industry professionals.

Read transcript

Hi, I’m Felipe, founder of GMP Bridge. The GMP Bridge Briefing is a monthly email for people making quality decisions in biopharma and cell and gene therapies. I will share a few developments I think deserve a closer look, what they mean in practice, and my own perspective from working with quality teams. If that sounds useful for your work, you can request access below. See you in your inbox.

WHAT YOU RECEIVE

A few primary-source signals on GMP, inspections, manufacturing and technology, and the decision each one creates. An anonymised field reality from our work. One deeper article and a question you can answer directly.

WHO IT IS FOR

Heads and directors of Quality, Manufacturing, Operations, Technical Operations and CMC in biopharma, biotech, advanced therapies and CDMOs. Senior team members and selected investors or advisers are also welcome.

How access works

1

Request access with your company email.

2

Confirm your email via the link we send.

3

We review your request and get back to you.

 

Request access

Your request could not be saved. Please try again.
Thank you. Please confirm your email address using the link we have just sent from briefing@news.gmpbridge.com. If it doesn’t arrive within a few minutes, please check your spam folder.

The confirmation email comes from briefing@news.gmpbridge.com. If you don’t see it, please check your spam folder. Privacy policy